Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT06284629
Starting soon Not applicable

Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes.

NCT06284629 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2024-10-01
Last updated
2024-06-21

Condition(s) studied

Parkinson Disease

Investigational drug(s) / intervention(s)

NeptuneStandard clinical care

Neptune: Neptune is a software algorithm that utilizes data from wrist-worn sensors to track Parkinson motor symptoms and displays them in an easy to understand graph. Neptune Care is a mobile app that includes a patient portal, where patients can self-report symptoms, view their motor data and get medication reminders, and a physician portal, where the treating physician can view the objective motor data and patient-reported outcomes prior to a clinical visit.

Standard clinical care: Treatment and management according to standard clinical care

Study summary

The overall aim of the trial is to compare the efficacy of using wearables and patient-reported outcome measures versus standard care in enhancing the timeliness of referrals to advanced monitoring of treatments for people with Parkinson's Disease.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with Idiopathic Parkinson's Disease * Taking five or more doses of levodopa daily * Experiencing fluctuations in motor function with regards to OFF time and/or dyskinesia. * Able to utilize a digital product, either alone or assisted by a caregiver. Exclusion Criteria: * Consistent use of a wheelchair or walker which may interfere significantly with the remote monitoring of PD motor symptoms. * Lack of understanding and proficiency in the Danish language. * Inability to use wearable devices due to non-compliance, physical and/or skin sensitivity. * Suffering from severe psychiatric disorders. * Otherwise not qualified to receive advanced treatment (e.g., advanced cancer, severe heart failure). * Already undergoing advanced treatment. * Diagnosed with atypical or secondary parkinsonism. * Other patient groups otherwise deemed ineligible by the project manager.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Rigshospitalet Glostrup Glostrup Municipality Denmark
Odense University Hospital Odense Denmark

More Copenhagen University Hospital, Rigshospitalet trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06284629 on ClinicalTrials.gov ↗ ← All trials in Denmark